Non-pharmacological Auditory and Somatosensory Stimulation in Anesthetic Emergence

January 4, 2026 updated by: Guizhi Du, West China Hospital

Effects of Non-pharmacological Auditory and Somatosensory Stimulation on the Efficiency and Quality of Emergence From General Anesthesia

This study intends to employ verbal stimulation, tactile stimulation, and kinetic stimulation as interventions during the emergence phase from general anesthesia to facilitate recovery.

Study Overview

Detailed Description

General anesthesia is an indispensable component of modern surgical practice. While its induction mechanisms have been relatively well elucidated, the mechanisms underlying emergence-namely the restoration of consciousness following anesthesia-remain incompletely understood. Emergence from anesthesia represents a critical stage of anesthetic management, with its efficiency and quality directly influencing postoperative recovery, patient safety, and the incidence of complications. Traditionally, anesthesia induction and emergence were considered to be symmetrical and passive processes, with emergence regarded as the reverse of induction that naturally occurs as anesthetic drug concentrations decline. However, recent advances in neuroscience suggest that anesthetic emergence is not merely a passive reversal but rather an actively regulated, multidimensional neurophysiological process with modulatory potential, and it is not entirely symmetrical to induction. Studies have demonstrated that neuronal activity in the cortex, activation patterns of brain regions, and neurotransmitter regulation during emergence differ substantially from those observed during induction. Key regulatory pathways implicated in this process include orexinergic neurons and the locus coeruleus-noradrenergic system. These findings provide a theoretical foundation for strategies aimed at facilitating emergence from general anesthesia.

Evidence further indicates that the sequence of functional recovery across different brain regions is heterogeneous during emergence. Clinical observations suggest that auditory perception is among the earliest sensory modalities to recover during anesthetic emergence. This phenomenon is of notable clinical significance, as it underlies the longstanding use of auditory interventions-such as calling a patient's name or giving verbal commands-in the operating room. Compared with other sensory modalities such as vision or nociception, auditory pathways regain responsiveness earlier. Although the precise neural mechanisms remain unclear, they are likely related to the auditory system, language processing circuits, and higher-order cortical integration of language. Recent advances in neuroimaging techniques, including electroencephalography (EEG) and functional magnetic resonance imaging (fMRI), provide further support for this perspective. For example, a previous study demonstrated via intracranial recordings that during propofol anesthesia, the core auditory cortex continued to generate early auditory evoked potentials and frequency-following responses to 50 Hz sound stimuli, indicating preserved early cortical responses. Similarly, another study showed that following loss of consciousness, the primary auditory cortex retained rapid responses to auditory input, whereas higher-order cortical responses were markedly attenuated. These findings suggest that auditory cortices can respond to external auditory stimuli even in the early stages of emergence when anesthetic concentrations remain pharmacologically significant, thereby supporting the use of auditory stimulation in facilitating recovery. Moreover, recent studies have investigated how specific linguistic content (e.g., a patient's own name) and acoustic characteristics (e.g., familiar voices) influence emergence quality. One study found that calling a patient's name elicited stronger responses and facilitated awakening more effectively than generic verbal cues. Similarly, another research reported that playback of maternal voice recordings shortened extubation time and reduced the incidence of emergence delirium in pediatric patients.

In addition to auditory stimulation, non-verbal somatosensory interventions are also commonly applied in clinical practice to promote emergence. Nevertheless, research on the role of such non-verbal stimulation in emergence from general anesthesia remains limited. Previous research demonstrated that acupuncture at acupoints such as Renzhong and Yongquan could accelerate the recovery of consciousness after general anesthesia. However, standardized protocols and robust evidence supporting the use of mechanical somatosensory stimulation to facilitate emergence are currently lacking. And its specific stimulation methods, intensity, timing of intervention, and safety parameters remain unclear.

Animal studies demonstrated in that electrical stimulation of glutamatergic neurons in the brainstem parabrachial nucleus can induce recovery of the righting reflex and behavioral arousal in mice under sustained isoflurane anesthesia, accompanied by a marked reduction in electroencephalographic δ waves. Subsequent studies further confirmed that stimulating glutamatergic neurons in the parabrachial nucleus accelerated anesthetic emergence, underscoring the critical role of this brainstem pathway in arousal regulation. The parabrachial nucleus is an important node in the central arousal network; its activation drives norepinephrine and dopamine release from the hypothalamus and brainstem, thereby enhancing cortical arousal. These findings suggest that peripheral somatosensory stimulation may ascend via spinal pathways to brainstem structures, thereby activating ascending arousal centers and accelerating recovery of consciousness. This provides a neurobiological basis for the use of peripheral somatosensory or spinal stimulation as non-invasive awakening strategies; however, clinical trials systematically validating such interventions remain lacking.

Although numerous studies have explored pharmacologic and non-pharmacologic approaches to accelerate emergence from general anesthesia, there is a paucity of randomized controlled trials evaluating the effectiveness and safety of non-verbal somatosensory stimulation. This approach is simple to implement, has a favorable safety profile, and does not increase healthcare costs. Its effects on emergence efficiency, emergence quality, and postoperative complications (e.g., delayed emergence, agitation) warrant systematic investigation, and such findings would provide evidence for clinical guidelines on anesthetic emergence.

Furthermore, electroencephalography (EEG), as a non-invasive method for real-time monitoring of brain function, is widely applied in assessing anesthetic depth and recovery of consciousness. Studies have shown that during emergence from general anesthesia, EEG exhibits characteristic changes, such as a reduction in high-amplitude slow waves, reappearance of α oscillations, and a gradual increase in β activity. Incorporating EEG frequency dynamics into the study design may help elucidate the neural mechanisms by which stimulation interventions modulate the arousal process, offering more direct neurophysiological evidence to optimize both monitoring and intervention strategies during anesthetic emergence.

In summary, the investigators propose to conduct a prospective, randomized controlled clinical trial to systematically investigate, in patients undergoing laparoscopic abdominal surgery under combined intravenous and inhalational general anesthesia, the effects of non-verbal somatosensory stimulation, either alone or in combination with verbal stimulation, compared with the conventional approach of verbal name-calling. Outcomes of interest include postoperative emergence time, quality, and safety. This study aims to provide robust scientific evidence to inform optimized intervention strategies for anesthetic emergence.

Study Type

Interventional

Enrollment (Estimated)

205

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

    • Sichuan
      • Chengdu, Sichuan, China, 610041
        • Recruiting
        • West China Hospital of Sichuan University
        • Contact:

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  1. Adult patients aged 18 to 65 years, with American Society of Anesthesiologists (ASA) physical status I-III;
  2. Scheduled for laparoscopic abdominal surgery, including gastric, colorectal, or biliary procedures;

Exclusion Criteria:

  1. ASA physical status IV;
  2. Body mass index (BMI) greater than 30 kg/m²;
  3. Presence of underlying neurological dysfunction, cognitive impairment, or auditory disorders;
  4. Neurological, cardiovascular, hepatic, or renal dysfunction;
  5. Current use of antipsychotic medications or a history of psychiatric illness;
  6. History of alcohol abuse or substance dependence;
  7. Exposure to general anesthesia or sedation within 1 month prior to surgery;
  8. Presence of intracranial implants or a history of epilepsy;
  9. Known allergy to any drugs used in this study;
  10. Preoperative use of electronic hearing aids or implanted auditory devices;
  11. Refusal to participate in the study.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Active Comparator: Verbal Stimulation Group:
Patients will wear headphones connected to a voice playback device that delivers pre-recorded verbal stimuli. Each voice message will last approximately 3 seconds, with a speech rate of 200-300 ms per character, and the volume will be set at a normal speaking level (60 dB). After each playback, there will be a 10-second interval before the next repetition, and the verbal stimulus will be played three times per intervention cycle.If the patient shows no eye opening or clear response, the standard verbal stimulation procedure will be repeated after a 3-minute interval, until a response is observed.
Experimental: Shoulder Tapping Group
No audio will be played through the patient's headphones. Upon discontinuation of anesthetic agents, the investigator will begin tapping the patient's left shoulder. All operators will receive standardized training to ensure procedural consistency. The tapping frequency will be 2 taps per second, i.e., six taps within 3 seconds, paced using a metronome to maintain rhythm uniformity. Each tapping event (six taps over 3 seconds) will last 3 seconds, followed by a 10-second interval before the next tapping event.
Experimental: Shoulder Shaking Group
No audio will be played through the patient's headphones. Upon discontinuation of anesthetic agents, the investigator will begin gently shaking the patient's left shoulder.All investigators will undergo standardized training to ensure consistency of operation. Each shaking event (three shakes within 3 seconds) will last 3 seconds, followed by a 10-second interval before the next shaking event. Each intervention cycle will include three shaking events.
Experimental: Combined Verbal + Shoulder Tapping Group
Patients will wear headphones connected to a voice playback device that delivers pre-recorded verbal stimuli. Each voice message will last approximately 3 seconds, with a speech rate of 200-300 ms per character, and the volume will be set at a normal speaking level (60 dB). After each playback, there will be a 10-second interval before the next repetition, and the verbal stimulus will be played three times per intervention cycle.If the patient shows no eye opening or clear response, the standard verbal stimulation procedure will be repeated after a 3-minute interval, until a response is observed.
No audio will be played through the patient's headphones. Upon discontinuation of anesthetic agents, the investigator will begin tapping the patient's left shoulder. All operators will receive standardized training to ensure procedural consistency. The tapping frequency will be 2 taps per second, i.e., six taps within 3 seconds, paced using a metronome to maintain rhythm uniformity. Each tapping event (six taps over 3 seconds) will last 3 seconds, followed by a 10-second interval before the next tapping event.
Experimental: Combined Verbal + Shoulder Shaking Group
Patients will wear headphones connected to a voice playback device that delivers pre-recorded verbal stimuli. Each voice message will last approximately 3 seconds, with a speech rate of 200-300 ms per character, and the volume will be set at a normal speaking level (60 dB). After each playback, there will be a 10-second interval before the next repetition, and the verbal stimulus will be played three times per intervention cycle.If the patient shows no eye opening or clear response, the standard verbal stimulation procedure will be repeated after a 3-minute interval, until a response is observed.
No audio will be played through the patient's headphones. Upon discontinuation of anesthetic agents, the investigator will begin gently shaking the patient's left shoulder.All investigators will undergo standardized training to ensure consistency of operation. Each shaking event (three shakes within 3 seconds) will last 3 seconds, followed by a 10-second interval before the next shaking event. Each intervention cycle will include three shaking events.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Time to first eye opening
Time Frame: Perioperative
defined as the interval from discontinuation of anesthetic agents to the moment the patient opens both eyes in response to a verbal command and is able to keep them open for at least 5 seconds.
Perioperative

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Changes in EEG power
Time Frame: Perioperative
Alterations in power across specific EEG frequency bands (e.g., Delta, Theta, Alpha, Beta) at the time of first eye opening
Perioperative
Time to target BIS values
Time Frame: Perioperative
Time required for the BIS to reach 70, 80, and 90 after discontinuation of desflurane
Perioperative
Extubation time
Time Frame: Perioperative
Interval from discontinuation of desflurane to removal of the endotracheal tube
Perioperative
Emergence agitation
Time Frame: Perioperative

Highest score on the Riker Sedation-Agitation Scale (SAS) observed during emergence.

The SAS ranges from 1 to 7, with higher scores indicating greater agitation and a worse outcome.

Assessed from extubation to time before arrival in the post-anesthesia care unit.

Perioperative
Sedation depth after extubation
Time Frame: Perioperative

Sedation level assessed using the Richmond Agitation-Sedation Scale (RASS) during emergence from anesthesia.

The RASS ranges from -5 (unarousable) to +4 (combative), with higher scores indicating more agitation and lower scores indicating deeper sedation.

Assessed from extubation to 30 minutes after arrival in the post-anesthesia care unit.

Perioperative
Hemodynamic parameters
Time Frame: Perioperative
Mean arterial pressure (MAP) and heart rate (HR) recorded
Perioperative
Length of stay in PACU
Time Frame: Perioperative
Length of stay in PACU
Perioperative
Postoperative analgesic use
Time Frame: Perioperative
Total amount of analgesic administered in the PACU
Perioperative
Use of antiemetics
Time Frame: Perioperative
Antiemetic medications administered in the PACU
Perioperative
Incidence of agitation in the PACU
Time Frame: Perioperative
Proportion of patients with a Riker Sedation-Agitation Scale score ≥ 5. Assessed in the first 30 minutes after arrival in the post-anesthesia care unit.
Perioperative
Pain scores in the PACU
Time Frame: Perioperative

Pain intensity assessed using the Numeric Rating Scale (NRS), where 0 indicates no pain and 10 indicates the worst possible pain.

Higher scores indicate more severe pain. Assessed at 10 minutes, 20 minutes, and 30 minutes after arrival in the post-anesthesia care unit.

Perioperative

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

October 11, 2025

Primary Completion (Estimated)

June 30, 2027

Study Completion (Estimated)

June 30, 2027

Study Registration Dates

First Submitted

December 15, 2025

First Submitted That Met QC Criteria

January 4, 2026

First Posted (Actual)

January 14, 2026

Study Record Updates

Last Update Posted (Actual)

January 14, 2026

Last Update Submitted That Met QC Criteria

January 4, 2026

Last Verified

January 1, 2026

More Information

Terms related to this study

Other Study ID Numbers

  • WestChinaHospital 2025(1900)

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

YES

IPD Plan Description

Deidentified individual participant data will be available upon reasonable request from the corresponding author after publication and ethical approval. Data will be shared via email request to the corresponding author within 6 months after publication.

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on General Anesthetic

Clinical Trials on Verbal Stimulation

Subscribe